期刊
CHEMMEDCHEM
卷 9, 期 12, 页码 2633-2637出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201402333
关键词
antivirals; inhibitors; lipids; phospholipaseD; PLD2
资金
- US National Institutes of Health (NIH) / Molecular Libraries Probe Production Centers Network (MLPCN) [U54 MH084659]
- Warren Family and Foundation
- Predoctoral ACS Medicinal Chemistry Fellowship
Further chemical optimization of the halopemide-derived family of dual phospholipaseD1/2 (PLD1/2) inhibitors afforded ML395 (VU0468809), a potent, >80-fold PLD2 selective allosteric inhibitor (cellular PLD1, IC50>30000nM; cellular PLD2, IC50=360nM). Moreover, ML395 possesses an attractive in vitro DMPK profile, improved physiochemical properties, ancillary pharmacology (Eurofins Panel) cleaner than any other reported PLD inhibitor, and has been found to possess interesting activity as an antiviral agent in cellular assays against a range of influenza strains (H1, H3, H5 and H7).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据